Article

Visual impairment due to cataract affects mostly patients in poverty, according to study

People with cataract-induced visual impairment are more likely to live in poverty than those with normal sight, according to a study conducted in three developing countries-Kenya, the Philippines, and Bangladesh.

London-People with cataract-induced visual impairment are more likely to live in poverty than those with normal sight, according to a study conducted in three developing countries-Kenya, the Philippines, and Bangladesh.

Cataract is the cause of more than one-third of the world’s 45 million people affected by blindness. The treatment is relatively inexpensive and simple, but some evidence suggests that lack of money is a major barrier to have cataract surgery by individuals in poor countries.

The study looked at 596 people aged 50 years or more with severe cataract-induced visual impairment, matching each case with a normally sighted person of similar age and sex living nearby. The measure of poverty was by monthly per capita expenditure (PCE), self-rated wealth, and ownership of assets.

For all three countries, the cases were more likely than controls to be in the lowest quarter of the range of PCEs for that country. Risk of cataract-related visual impairment increased as PCE decreased in all three countries. No consistent association existed, however, between PCE and the level of cataract-induced visual impairment.

"This study confirms an association between poverty and blindness and highlights the need for increased provision of cataract surgery to poor people, particularly since cataract surgery is a highly cost-effective intervention in these settings," said the authors from the International Centre for Eye Health, London School of Hygiene and Tropical Medicine.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.